Fig. 6From: Potentiation of amyloid beta phagocytosis and amelioration of synaptic dysfunction upon FAAH deletion in a mouse model of Alzheimer's diseaseMixed DAM signature in microglia from 5xFAD/FAAH−/− mice. A–C Expression levels of phagocytic markers CD33 (A), CX3CR1 (B) and CD200R (C), obtained from hippocampal extracts after RT-qPCR. E–G Messenger RNA levels of DAM markers APOE (D), CLEC7A (E) and CTSD (F), obtained from hippocampal extracts after RT-qPCR. Two-way ANOVA followed by Tukey’s test (**p < 0.01, ****p < 0.0001) (n = 6–8 animals in each group). Graphs represent mean ± s.e.mBack to article page